β³ Fetching live dividend data...
Home βΊ Calculator βΊ OMIC Dividend Calculator 2026
Singular Genomics Systems, Inc. Β· NASDAQ
Price: $20.01 Β· Annual div: $2.00/share Β· Frequency: quarterly Β· Payout ratio: 50% Β· Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in OMIC β $25.9K in 10 years Β· $196.32/month
Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associated menu of consumable kits. It also offers PX Integrated Solution that combines single cell analysis, spatial analysis, genomics, and proteomics in one integrated instrument providing a versatile multiomics solution. The company has partnerships with Agilent Technologies, Dovetail Genomics, Lexogen, New England Biolab, QIAGEN, Roche, Twist Bioscience, and Watchmaker Genomics to validate their library preparation kits on the G4, as well as the Broad Institute of MIT and Harvard to connect the G4 to Terra platform, a data platform. Singular Genomics Systems, Inc. was incorporated in 2016 and is headquartered in La Jolla, California.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. Β· Privacy Policy
Ready to invest? Open OMIC position with:
Real after-tax yield depends on where you live and how you hold OMIC.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| πΊπΈ Roth IRA / 401k | 0% | 10.00% | 7.20% | $1,000 / yr |
| πΊπΈ US Taxable (15%) β | 15% | 8.50% | 5.70% | $850 / yr |
| πΊπΈ US Taxable (20%) | 20% | 8.00% | 5.20% | $800 / yr |
| π¬π§ UK ISA | 0% | 10.00% | 7.20% | $1,000 / yr |
| π¬π§ UK Taxable | 8.75% | 9.13% | 6.33% | $913 / yr |
| π¨π¦ TFSA | 0% | 10.00% | 7.20% | $1,000 / yr |
| π¨π¦ CA Taxable | 25% | 7.50% | 4.70% | $750 / yr |
| π¦πΊ Super (pension) | 15% | 8.50% | 5.70% | $850 / yr |
| π¦πΊ AU Taxable | 30% | 7.00% | 4.20% | $700 / yr |
| π©πͺ DE Taxable | 26.375% | 7.36% | 4.56% | $736 / yr |
| π«π· FR Taxable | 30% | 7.00% | 4.20% | $700 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr Β· πΊπΈ US Taxable (15%) Β· static projection (no growth assumed).
OMIC pays quarterly β 4 times per year. Next ex-div: TBD.
How OMIC compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024β2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for OMIC sourced from FMP /financial-growth endpoint β real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| D-Return | 2025-02-21 | 372,000 | $20.00 | $7.44M | ||
| D-Return | 2025-02-21 | 5,271 | β | β | ||
| D-Return | 2025-02-21 | 42,881 | $18.90 | $810.5K | ||
| D-Return | 2025-02-21 | 85 | $20.00 | $1.7K | ||
| D-Return | 2025-02-21 | 15,555 | $38.40 | $597.3K | ||
| D-Return | 2025-02-21 | 22,874 | β | β | ||
| D-Return | 2025-02-21 | 33,333 | $225.00 | $7.50M | ||
| D-Return | 2025-02-21 | 6,666 | $38.40 | $256.0K | ||
| D-Return | 2025-02-21 | 1,874 | β | β | ||
| D-Return | 2025-02-21 | 6,249 | $225.00 | $1.41M |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores β lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the OMIC dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer β
Real users. No sign-up required to leave a review.
βFinally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.β
βI've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly β $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.β
βReally solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.β
βAs someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.β
βThe Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.β
Reviews reflect users' personal experiences. Not financial advice.
Leave a review β